Fermenta Q3FY25 Consolidated Net Profit INR 37.9 crore, up 379 % YoY and 341% QoQ
Feb 13, 2025
Mumbai (Maharashtra) [India], February 13: Fermenta Biotech Limited, India's leading manufacturer of premium-grade APIs, intermediates, and mixes of vitamins and minerals for the global markets, today announced its unaudited financial results for the quarter and nine months ended 31 December 2024 (9MFY25). Consolidated revenue (other than from real estate and transfer of lease related rights) for 9MFY25 was INR 286.2 crore, up 70 % from 9MFY24; EBITDA for 9MFY25 was INR 50.6 crore against loss of INR 32.9 crore for 9MFY24.